Updated: January 14, 2026
How to Help Your Patients Save Money on Apretude: A Provider's Guide to Savings Programs
Author
Peter Daggett

Summarize with AI
- The ACA Preventive Services Mandate: Your Most Powerful Tool
- Medicare: $0 Coverage for At-Risk Beneficiaries
- Medicaid: ACA Expansion Coverage
- ViiVConnect Savings Program: Commercially Insured Patients
- ViiV Patient Assistance Program: Uninsured Patients
- State AIDS Drug Assistance Programs (ADAPs): A Critical Safety Net
- Building a Practice Workflow for Cost Navigation
- When a Patient Gets Charged Despite ACA Coverage
Most Apretude patients pay $0. Learn how providers can navigate ACA mandates, ViiVConnect savings, patient assistance, and ADAP programs to eliminate cost barriers for their patients.
Apretude's list price of approximately $22,000 per year can trigger immediate patient concern — but for most insured patients in 2026, that number is irrelevant. The combination of ACA mandates, Medicare coverage, manufacturer savings programs, and state assistance programs means most patients should pay $0 or very little. This guide walks providers through every available pathway so patients never have to decline Apretude due to cost.
The ACA Preventive Services Mandate: Your Most Powerful Tool
The Affordable Care Act requires most private insurance plans to cover Grade A USPSTF preventive services with no cost-sharing. PrEP holds a Grade A recommendation. Covered services include:
Apretude (the medication itself)
Injection administration services
HIV testing required before each injection
STI screening and counseling visits
Kidney function monitoring as part of PrEP care
Coverage applies before the deductible and without copays or coinsurance for most commercial plans. However, implementation varies. A 2023 study found that approximately 36% of PrEP users were charged cost-sharing despite federal requirements — meaning provider advocacy can make a real difference.
Medicare: $0 Coverage for At-Risk Beneficiaries
Medicare covers Apretude and all related HIV prevention services at $0 out-of-pocket cost for beneficiaries at increased risk of HIV acquisition. This includes Part A/B benefits (for clinic-administered injectable) and Part D for any oral components. Medicare Part D plans have a $2,100 annual out-of-pocket cap as of 2026.
Key billing note: When billing Medicare for injectable Apretude, code the drug administration correctly under the medical benefit. HIV testing under preventive coverage uses appropriate CPT codes for preventive services.
Medicaid: ACA Expansion Coverage
Medicaid expansion programs must cover PrEP without cost-sharing. However, non-expansion Medicaid programs may have different rules. Check your state's Medicaid formulary. Many states also have supplemental programs and ADAP coverage that extends beyond base Medicaid benefits.
ViiVConnect Savings Program: Commercially Insured Patients
For patients with commercial insurance who still face out-of-pocket costs, ViiV Healthcare's Apretude Savings Program through ViiVConnect can reduce costs to as little as $0. Key details for providers:
Enrollment: ViiVConnect.com or 1-877-844-8872
Eligibility: Commercially insured patients; not available for Medicare Part D or Medicaid as primary insurance
Provider tip: Your practice can enroll patients during the Apretude initiation process — ViiVConnect coordinates the enrollment and insurance verification concurrently with your specialty pharmacy setup
ViiV Patient Assistance Program: Uninsured Patients
For uninsured patients, ViiV Healthcare's Patient Assistance Program provides Apretude at no charge for eligible patients. Provider guidance:
Eligibility: Most uninsured patients with limited income qualify
Process: Application available at ViiVConnect.com/patient-assistance-program; can be submitted by your office by mail or fax; also available by calling 1-844-588-3288
Medicare Part D patients may qualify under certain criteria — check program terms
Additional grant funding up to $5,000/year may be available through supplemental programs for patients in Puerto Rico and other situations — review full program terms
State AIDS Drug Assistance Programs (ADAPs): A Critical Safety Net
Ryan White-funded AIDS Drug Assistance Programs cover HIV medications and PrEP — including Apretude — in many states. ADAP eligibility is based on income and is designed to help patients who fall through the cracks of other programs. For practices in states with robust ADAP programs, this is an important safety net for patients who:
Are uninsured but may not qualify for the ViiV program
Are underinsured with high deductibles
Are in the coverage gap between Medicaid and commercial insurance
Building a Practice Workflow for Cost Navigation
Practices that successfully minimize patient cost barriers for Apretude typically have:
A standard insurance pre-authorization template for Apretude that references the ACA preventive mandate and USPSTF Grade A recommendation
An enrollment workflow with ViiVConnect that runs concurrent with specialty pharmacy setup — patients are enrolled during the initiation visit, not after
A staff member or navigator designated to handle PA requests, savings program enrollment, and insurance disputes
Knowledge of your state ADAP formulary and eligibility criteria for last-resort cases
When a Patient Gets Charged Despite ACA Coverage
If a patient is incorrectly charged for Apretude or related services:
Document the date of service, service codes, and amount charged
File an internal appeal with the payer, referencing ACA Section 2713 and USPSTF Grade A for PrEP
If the internal appeal fails, file an external review request
Contact the state insurance commissioner if the payer refuses to comply with the mandate
medfinder for Providers offers additional tools to support your practice in helping patients access medications. Visit medfinder.com/providers for more information.
Frequently Asked Questions
Most patients pay $0. The ACA mandates $0 cost-sharing for Apretude and related PrEP services under most commercial plans and Medicaid expansion. Medicare also covers it at $0. The ViiVConnect Savings Program can cover remaining costs for commercially insured patients, and the Patient Assistance Program can provide it free for uninsured patients.
Call ViiVConnect at 1-877-844-8872 or visit ViiVConnect.com. You can enroll patients during the initiation process — the program runs concurrent with specialty pharmacy setup. You'll need the patient's insurance information and a completed enrollment form.
Billing typically includes: J-code for Apretude (confirm current code with ViiVConnect), CPT 96372 for the injection administration, and preventive visit codes (99381-99397) for the clinical visit. HIV testing is billed using appropriate lab codes as a preventive service. Consult your billing department and ViiVConnect's reimbursement support for your specific payer mix.
Many state AIDS Drug Assistance Programs (ADAPs) include PrEP on their formularies, including injectable options like Apretude. Eligibility is income-based and varies by state. Check your state health department's HIV prevention program or the NASTAD ADAP Watch resource for state-by-state coverage details.
File an internal appeal referencing the ACA Section 2713 preventive services mandate and the USPSTF Grade A recommendation for PrEP. Include clinical notes documenting HIV risk. If the internal appeal fails, pursue external review. Most denials for PrEP coverage are overturned on appeal when properly documented. ViiVConnect's reimbursement support team can also help — call 1-877-844-8872.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Apretude also looked for:
More about Apretude
36,771 have already found their meds with Medfinder.
Start your search today.





